Heart

Artificial chords in endoscopic mitral valve repair: a comparative analysis of surgical techniques and long-term outcomes

Background The use of artificial chords for mitral valve prolapse during minimally invasive mitral valve repair (MIMVR) has ...
BMJ Open Sport & Exercise Medicine

Shall we go for a walk? A cross-sectional study comparing the 6 min walk test and cardiopulmonary exercise test for assessing cardiorespiratory fitness in de novo kidn…

Background and objective Kidney transplant recipients (KTRs) face elevated cardiovascular risk, partly due to reduced ...
infomeddnews

Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention

Mechanism-Driven Study Design Focused on Capital Efficiency and Accelerated Development for Near-Term Value Creation, Addressing a $2 Billion Potential Target Market Medicus Pharma Ltd. (NASDAQ: MDCX) ...
FierceBiotech

Aspen's 1-year data for Parkinson's cell therapy plant seeds for phase 3 trial

Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, with the San Diego biotech now planning for a pivotal phase 3 trial later ...
Seeking Alpha

Telix Pharmaceuticals Limited (TLX) Discusses ProstACT Global Phase 3 Study Part 1 Results and Safety Profile Transcript

Good morning, everybody. My name is Kyahn Williamson, SVP of Investor Relations and Corporate Communications at Telix. And we're very pleased to welcome you today to our investor call and webcast to ...
Business Wire

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE: BMY) today announced positive interim Phase 3 results from the SUCCESSOR-2 study (NCT05552976). In the trial, oral mezigdomide in ...
Cure Today

Iza-Bren Improves Survival in Phase 3 Triple-Negative Breast Cancer Study

A pre-specified interim analysis showed dual primary endpoint success, with improved PFS and OS versus physician’s-choice chemotherapy in taxane-progressed advanced TNBC. BL-B01D1-307 was a randomized ...
Morningstar

Pentixapharm Receives FDA Feedback for Phase 3 Diagnostic Study in Hypertension

Formal written minutes from the U.S. FDA confirms no major concerns identified for the planned Phase 3 PANDA study of [⁶⁸Ga]Ga-PentixaFor in treatment-resistant hypertension and Primary Aldosteronism ...
MarketWatch

Zenas BioPharma Stock Plummets Despite Positive Phase 3 Study Results

Zenas BioPharma shares fell sharply after the company reported favorable Phase 3 study results for obexelimab in immunoglobulin G4-related disease. The stock fell 56% to $15.22. Despite Monday's ...
Pulmonaryhypertensionnews.com

Phase 3 trials now recruiting people with PH-HFpEF to test TNX-103

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Two Phase 3 clinical trials are now recruiting participants to ...
Monthly Prescribing Reference

Tolebrutinib Misses Primary Endpoint in Phase 3 PPMS Study

Findings showed treatment with tolebrutinib did not significantly delay disability progression compared with placebo. A phase 3 study evaluating tolebrutinib for the treatment of primary progressive ...